Bionomics Limited (BNOX) stock declined over -1.70%, trading at $0.60 on NASDAQ, down from the previous close of $0.61. The stock opened at $0.59, fluctuating between $0.58 and $0.64 in the recent session.
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.
Employees | 8 |
Beta | -0.123 |
Sales or Revenue | $432.67K |
5Y Sales Change% | -0.984% |
Fiscal Year Ends | June |
Sector | Healthcare |
Industry | Biotechnology |
Bionomics Limited (NASDAQ: BNOX) stock price is $0.60 in the last trading session. During the trading session, BNOX stock reached the peak price of $0.64 while $0.58 was the lowest point it dropped to. The percentage change in BNOX stock occurred in the recent session was -1.7% while the dollar amount for the price change in BNOX stock was -$0.01.
The NASDAQ listed BNOX is part of Biotechnology industry that operates in the broader Healthcare sector. Bionomics Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
BNOX's closing price is 19% higher than its 52-week low of $0.50 where as its distance from 52-week high of $6.41 is -90.72%.
Number of BNOX employees currently stands at 8.
Official Website of BNOX is: https://www.bionomics.com.au
BNOX could be contacted at phone 618 835 46100 and can also be accessed through its website. BNOX operates from 200 Greenhill Road, Eastwood, SA 5063, Australia.
BNOX stock volume for the day was 45.64K shares. The average number of BNOX shares traded daily for last 3 months was 962.61K.
The market value of BNOX currently stands at $7.11M with its latest stock price at $0.60 and 11.95M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com